Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Global In-Vitro Toxicology and Toxicity Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by In-Vitro Toxicology and Toxicity Testing Revenue
  • 1.4 Covid-19 Implications on Market by Type
    • 1.4.1 Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Cell Culture Technology
    • 1.4.3 High Throughput Technologies
    • 1.4.4 Molecular Imaging Technologies
    • 1.4.5 Omics Technologies
  • 1.5 Market by Application
    • 1.5.1 Global In-Vitro Toxicology and Toxicity Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 Pharmaceutical Industry
    • 1.5.3 Chemical Industry
    • 1.5.4 Food Industry
    • 1.5.5 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): In-Vitro Toxicology and Toxicity Testing Industry Impact
    • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.6.2 Covid-19 Impact: Commodity Prices Indices
    • 1.6.3 Covid-19 Impact: Global Major Government Policy
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends

  • 2.1 Covid-19 Implications on Global In-Vitro Toxicology and Toxicity Testing Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global In-Vitro Toxicology and Toxicity Testing Growth Trends by Regions
    • 2.2.1 In-Vitro Toxicology and Toxicity Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 In-Vitro Toxicology and Toxicity Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 In-Vitro Toxicology and Toxicity Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key In-Vitro Toxicology and Toxicity Testing Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Market Size
    • 3.1.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue (2015-2020)
    • 3.1.2 Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global In-Vitro Toxicology and Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio
    • 3.2.1 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicology and Toxicity Testing Revenue in 2019
  • 3.3 In-Vitro Toxicology and Toxicity Testing Key Players Head office and Area Served
  • 3.4 Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
  • 3.5 Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

  • 4.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

  • 5.1 Global In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)
  • 5.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

  • 6.1 North America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 6.2 In-Vitro Toxicology and Toxicity Testing Key Players in North America (2019-2020)
  • 6.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
  • 6.4 North America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

  • 7.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 7.2 In-Vitro Toxicology and Toxicity Testing Key Players in Europe (2019-2020)
  • 7.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
  • 7.4 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

8 China Impact of COVID-19

  • 8.1 China In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 8.2 In-Vitro Toxicology and Toxicity Testing Key Players in China (2019-2020)
  • 8.3 China In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
  • 8.4 China In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

  • 9.1 Japan In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 9.2 In-Vitro Toxicology and Toxicity Testing Key Players in Japan (2019-2020)
  • 9.3 Japan In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
  • 9.4 Japan In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

  • 10.1 Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 10.2 In-Vitro Toxicology and Toxicity Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

11 India Impact of COVID-19

  • 11.1 India In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 11.2 In-Vitro Toxicology and Toxicity Testing Key Players in India (2019-2020)
  • 11.3 India In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
  • 11.4 India In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

  • 12.1 Central & South America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 12.2 In-Vitro Toxicology and Toxicity Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 GE Healthcare
    • 13.1.1 GE Healthcare Company Details
    • 13.1.2 GE Healthcare Business Overview and Its Total Revenue
    • 13.1.3 GE Healthcare In-Vitro Toxicology and Toxicity Testing Introduction
    • 13.1.4 GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020))
    • 13.1.5 GE Healthcare Recent Development and Reaction to COVID-19
  • 13.2 Thermo Fisher Scientific
    • 13.2.1 Thermo Fisher Scientific Company Details
    • 13.2.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
    • 13.2.3 Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Introduction
    • 13.2.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 13.2.5 Thermo Fisher Scientific Recent Development and Reaction to COVID-19
  • 13.3 Bio-Rad Laboratories
    • 13.3.1 Bio-Rad Laboratories Company Details
    • 13.3.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
    • 13.3.3 Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Introduction
    • 13.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 13.3.5 Bio-Rad Laboratories Recent Development and Reaction to COVID-19
  • 13.4 Agilent Technologies
    • 13.4.1 Agilent Technologies Company Details
    • 13.4.2 Agilent Technologies Business Overview and Its Total Revenue
    • 13.4.3 Agilent Technologies In-Vitro Toxicology and Toxicity Testing Introduction
    • 13.4.4 Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 13.4.5 Agilent Technologies Recent Development and Reaction to COVID-19
  • 13.5 Cyprotex
    • 13.5.1 Cyprotex Company Details
    • 13.5.2 Cyprotex Business Overview and Its Total Revenue
    • 13.5.3 Cyprotex In-Vitro Toxicology and Toxicity Testing Introduction
    • 13.5.4 Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 13.5.5 Cyprotex Recent Development and Reaction to COVID-19
  • 13.6 Covance
    • 13.6.1 Covance Company Details
    • 13.6.2 Covance Business Overview and Its Total Revenue
    • 13.6.3 Covance In-Vitro Toxicology and Toxicity Testing Introduction
    • 13.6.4 Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 13.6.5 Covance Recent Development and Reaction to COVID-19
  • 13.7 Bioreliance
    • 13.7.1 Bioreliance Company Details
    • 13.7.2 Bioreliance Business Overview and Its Total Revenue
    • 13.7.3 Bioreliance In-Vitro Toxicology and Toxicity Testing Introduction
    • 13.7.4 Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 13.7.5 Bioreliance Recent Development and Reaction to COVID-19
  • 13.8 Catalent
    • 13.8.1 Catalent Company Details
    • 13.8.2 Catalent Business Overview and Its Total Revenue
    • 13.8.3 Catalent In-Vitro Toxicology and Toxicity Testing Introduction
    • 13.8.4 Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 13.8.5 Catalent Recent Development and Reaction to COVID-19
  • 13.9 Charles River Laboratories International
    • 13.9.1 Charles River Laboratories International Company Details
    • 13.9.2 Charles River Laboratories International Business Overview and Its Total Revenue
    • 13.9.3 Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Introduction
    • 13.9.4 Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 13.9.5 Charles River Laboratories International Recent Development and Reaction to COVID-19
  • 13.10 Alere
    • 13.10.1 Alere Company Details
    • 13.10.2 Alere Business Overview and Its Total Revenue
    • 13.10.3 Alere In-Vitro Toxicology and Toxicity Testing Introduction
    • 13.10.4 Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 13.10.5 Alere Recent Development and Reaction to COVID-19
  • 13.11 Eurofins Scientific
    • 10.11.1 Eurofins Scientific Company Details
    • 10.11.2 Eurofins Scientific Business Overview and Its Total Revenue
    • 10.11.3 Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Introduction
    • 10.11.4 Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 10.11.5 Eurofins Scientific Recent Development and Reaction to COVID-19
  • 13.12 Life Technologies Corporation
    • 10.12.1 Life Technologies Corporation Company Details
    • 10.12.2 Life Technologies Corporation Business Overview and Its Total Revenue
    • 10.12.3 Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Introduction
    • 10.12.4 Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 10.12.5 Life Technologies Corporation Recent Development and Reaction to COVID-19
  • 13.13 Quest Diagnostics
    • 10.13.1 Quest Diagnostics Company Details
    • 10.13.2 Quest Diagnostics Business Overview and Its Total Revenue
    • 10.13.3 Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Introduction
    • 10.13.4 Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 10.13.5 Quest Diagnostics Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    In-Vitro Toxicology and Toxicity Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global In-Vitro Toxicology and Toxicity Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the In-Vitro Toxicology and Toxicity Testing market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyzes the impact of Coronavirus COVID-19 on the In-Vitro Toxicology and Toxicity Testing industry.

    The key players covered in this study
    GE Healthcare
    Thermo Fisher Scientific
    Bio-Rad Laboratories
    Agilent Technologies
    Cyprotex
    Covance
    Bioreliance
    Catalent
    Charles River Laboratories International
    Alere
    Eurofins Scientific
    Life Technologies Corporation
    Quest Diagnostics

    Market segment by Type, the product can be split into
    Cell Culture Technology
    High Throughput Technologies
    Molecular Imaging Technologies
    Omics Technologies
    Market segment by Application, split into
    Pharmaceutical Industry
    Chemical Industry
    Food Industry
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global In-Vitro Toxicology and Toxicity Testing status, future forecast, growth opportunity, key market and key players.
    To present the In-Vitro Toxicology and Toxicity Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of In-Vitro Toxicology and Toxicity Testing are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
    Buy now